Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07291427 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chronic Subdural Hematoma Embolization With Detachable Coils

Study acronym: SEED
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 1 → 5 locations
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Collaborators: 2 to 3
  2. Recruitment opened
    • Start date changed from estimate of Jul 1, 2026 to Jun 2, 2026
    • Site details revised
    v3
  3. Start date: Mar 1, 2026 to Jul 1, 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
Trial Details
NCT Number NCT07291427
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: John Muir Health, Carondelet Neurological Institute, Balt USA
Conditions
(from sponsor)		 Chronic Subdural Hemorrhage (cSDH)
Related terms Hematoma, Subdural, Hematoma, Subdural, Chronic
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov